Andrew Balo
Chief Tech/Sci/R&D Officer at DEXCOM, INC.
Net worth: 11 M $ as of 2024-03-30
Profile
Mr. Andrew K. Balo is an EVP-Clinical Affairs, Regulatory Strategy at DexCom, Inc. Mr. Balo was previously employed as a Vice President-Regulatory & Clinical Affairs by InnerCool Therapies, Inc., a VP-Quality, Regulatory & Clinical Affairs by St. Jude Medical LLC, and a Vice President-Rgulatory & Clinical Affairs by Endocardial Solutions, Inc. He received his undergraduate degree from the University of Maryland.
Known holdings in public companies
Company | Date | Number of shares | Valuation | Valuation date |
---|---|---|---|---|
DEXCOM, INC.
0.02% | 2023-03-09 | 81,120 ( 0.02% ) | 11 M $ | 2024-03-30 |
Andrew Balo active positions
Companies | Position | Start |
---|---|---|
DEXCOM, INC. | Chief Tech/Sci/R&D Officer | 2002-01-31 |
Former positions of Andrew Balo
Companies | Position | End |
---|---|---|
Post-Hypothermia Corp.
Post-Hypothermia Corp. Medical SpecialtiesHealth Technology Post-Hypothermia Corp. develops and provides temperature modulation therapy products for the healthcare industry. It also provides CoolBlue, a surface-based temperature modulation system that consists of a console and a disposable CoolBlue vest with upper thigh pads, which is designed for use in less acute patients or prolonged temperature management clinical settings. The company was founded by John D. Dobak in 1998 and is headquartered in San Diego, CA. | Chief Tech/Sci/R&D Officer | 2002-01-31 |
ST JUDE MEDICAL INC | Chief Tech/Sci/R&D Officer | 1996-12-31 |
Endocardial Solutions, Inc.
Endocardial Solutions, Inc. Medical SpecialtiesHealth Technology Endocardial Solutions, Inc. designs, develops and manufactures a minimally invasive diagnostic system that diagnoses within the span of a few heartbeats, arrhythmia, a potentially fatal abnormal heart rhythm. The company's EnSite catheters and clinical workstations produce a high-resolution, real-time, three-dimensional color display of electrical activity in the heart chamber, thus allowing electrophysiologists to locate and diagnose tachycardia in real-time and to determine the course of treatment. It was founded in 1992. The company is located in St. Paul, MN. | Chief Tech/Sci/R&D Officer | - |
Training of Andrew Balo
University of Maryland | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 1 |
---|---|
DEXCOM, INC. | Health Technology |
Private companies | 3 |
---|---|
St. Jude Medical LLC
St. Jude Medical LLC Medical SpecialtiesHealth Technology St. Jude Medical LLC develops, manufactures and distributes cardiovascular medical devices for the global cardiac rhythm management, cardiovascular and atrial fibrillation therapy areas and neurostimulation medical devices for the management of chronic pain. The company was founded by Manuel A. Villafana in 1976 and is headquartered in St. Paul, MN. | Health Technology |
Endocardial Solutions, Inc.
Endocardial Solutions, Inc. Medical SpecialtiesHealth Technology Endocardial Solutions, Inc. designs, develops and manufactures a minimally invasive diagnostic system that diagnoses within the span of a few heartbeats, arrhythmia, a potentially fatal abnormal heart rhythm. The company's EnSite catheters and clinical workstations produce a high-resolution, real-time, three-dimensional color display of electrical activity in the heart chamber, thus allowing electrophysiologists to locate and diagnose tachycardia in real-time and to determine the course of treatment. It was founded in 1992. The company is located in St. Paul, MN. | Health Technology |
Post-Hypothermia Corp.
Post-Hypothermia Corp. Medical SpecialtiesHealth Technology Post-Hypothermia Corp. develops and provides temperature modulation therapy products for the healthcare industry. It also provides CoolBlue, a surface-based temperature modulation system that consists of a console and a disposable CoolBlue vest with upper thigh pads, which is designed for use in less acute patients or prolonged temperature management clinical settings. The company was founded by John D. Dobak in 1998 and is headquartered in San Diego, CA. | Health Technology |
- Stock Market
- Insiders
- Andrew Balo